Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Re Post of Question

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Aug 10, 2021 9:27pm

111 Views

Post# 33683031

RE:Re Post of Question

Poor innocent NorCalTommy!

Just use your head and try to think. If you're able to. Maybe you could answer your simple question.

_______________________

NorCalTommy - (8/10/2021 4:01:16 PM)
Re Post of Question

Hello fellow TLT travellers- quick question (at the risk of being redundundant from my earlier post)-

As we have innovations & breakthroughs on the photosensitizers, i., the successor to TLD-1433 etc... will it require going back into clinical trials for the 'new / improved' PS?? or just an upgrade to the existing PS??

Anyone have insight into this process, would welcome your input!

Thanks!

NCT

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project